SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 103 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $357,000 | -93.1% | 65,497 | -90.5% | 0.00% | -90.9% |
| Q1 2021 | $5,162,000 | -31.1% | 690,167 | 0.0% | 0.02% | -21.4% |
| Q4 2020 | $7,488,000 | +22.7% | 690,167 | 0.0% | 0.03% | +16.7% |
| Q3 2020 | $6,101,000 | -17.1% | 690,167 | 0.0% | 0.02% | -25.0% |
| Q2 2020 | $7,357,000 | +79.7% | 690,167 | 0.0% | 0.03% | +28.0% |
| Q1 2020 | $4,093,000 | -14.2% | 690,167 | 0.0% | 0.02% | 0.0% |
| Q4 2019 | $4,769,000 | -52.9% | 690,167 | -29.2% | 0.02% | -63.8% |
| Q3 2019 | $10,119,000 | +12.1% | 974,835 | 0.0% | 0.07% | +13.1% |
| Q2 2019 | $9,027,000 | +71.8% | 974,835 | +69.6% | 0.06% | +79.4% |
| Q1 2019 | $5,254,000 | +64.1% | 574,835 | 0.0% | 0.03% | +30.8% |
| Q4 2018 | $3,202,000 | -53.2% | 574,835 | 0.0% | 0.03% | -42.2% |
| Q3 2018 | $6,846,000 | +16.6% | 574,835 | 0.0% | 0.04% | +2.3% |
| Q2 2018 | $5,869,000 | -21.3% | 574,835 | 0.0% | 0.04% | -30.2% |
| Q1 2018 | $7,461,000 | +33.4% | 574,835 | 0.0% | 0.06% | +31.2% |
| Q4 2017 | $5,593,000 | -33.9% | 574,835 | 0.0% | 0.05% | -30.4% |
| Q3 2017 | $8,462,000 | -8.5% | 574,835 | 0.0% | 0.07% | -14.8% |
| Q2 2017 | $9,249,000 | +184.0% | 574,835 | +181.1% | 0.08% | +200.0% |
| Q1 2017 | $3,257,000 | +31.0% | 204,465 | 0.0% | 0.03% | +12.5% |
| Q4 2016 | $2,486,000 | -12.3% | 204,465 | 0.0% | 0.02% | -7.7% |
| Q3 2016 | $2,836,000 | -23.6% | 204,465 | 0.0% | 0.03% | -33.3% |
| Q2 2016 | $3,711,000 | – | 204,465 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|